Global Think-Tank on Steatotic Liver Disease: Priorities for 2025 and Beyond

Date

26/11/2024

Hour

17:30 -18:15 CET

Place

Virtual

Speakers

Jeffrey V Lazarus, Kenneth Cusi, Nuria Alonso, Didac Mauricio, Maru Rinella

On 26 November 2024, an online webinar in Spanish will bring together a panel of experts from Spain and the USA to discuss the key takeaways from the May event. It will include a lively discussion on the priorities for 2025, with a focus on prevention of liver diseases in people living with obesity and/or diabetes, as well as how to address the MASLD/MASH public health threat.

This is a great opportunity for healthcare professionals, patients and researchers alike to get updated on the latest in early detection, prevention, treatment and care of SLD.

Key topics to be addressed:

1. Bridging the diagnostic gap: Addressing the disconnect between the rising prevalence of SLD and the low rates of diagnosis, discussing non-invasive testing, ensuring more patients receive timely diagnosis, education and care.
2. Prevention as key: Effective preventive strategies aimed at reducing MASLD/MASH, emphasising the roles of diet, exercise, and environmental pollutants.
3. The Future of Treatments: The vision for the recently US FDA-approved MASH treatment
4. The Multidisciplinary Approach: The importance of involving all stakeholders, not least endocrinologists.

TO REGISTER, CLICK HERE: https://docs.google.com/forms/d/e/1FAIpQLSemn-PVYnXttOMbaqTKZ1rphlhYgGt-0T9xTu9DY7BuAKNgsg/viewform

Speakers:

• Jeffrey V Lazarus, Head of Public Health Liver Group, ISGlobal (Spain)
• Kenneth Cusi, Professor of Medicine, Division of Endocrinology, Diabetes, and Metabolism, University of Florida, USA
• Nuria Alonso, Director of the Department of Endocrinology and Nutrition, Germans Trias i Pujol Hospital, Spain
• Didac Mauricio, Director of the Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau Ciberdem, Spain
• Maru Rinella, Gastroenterologist, Director of the Department of Metabolic and Fatty Liver Diseases, University of Chicago, USA